( An ISO 9001:2015 Certified International Journal )

An International Peer Reviewed Journal for Pharmaceutical, Medical & Biological Sciences

An Official Publication of Society for Advance Healthcare Research (Reg. No. : 01/01/01/31674/16)

European Journal of Pharmaceutical and Medical Research (EJPMR) has indexed with various reputed international bodies like : Google Scholar , Indian Science Publications , InfoBase Index (In Process) , SOCOLAR, China , Research Bible, Fuchu, Tokyo. JAPAN , International Society for Research activity (ISRA) , Scientific Indexing Services (SIS) , Polish Scholarly Bibliography , Global Impact Factor (GIF) (Under Process) , Universal Impact Factor , International Scientific Indexing (ISI), UAE  , Index Copernicus , CAS (A Division of American Chemical Society) USA (Under Process) , Directory of Open Access Journal (DOAJ, Sweden, in process) , UDLedge Science Citation Index , CiteFactor , Directory Of Research Journal Indexing (DRJI) , Indian citation Index (ICI) , Journal Index (JI, Under Process) , Directory of abstract indexing for Journals (DAIJ) , Open Access Journals (Under Process) , Impact Factor Services For International Journals (IFSIJ) , Cosmos Impact Factor , Jour Informatics (Under Process) , Eurasian Scientific Journal Index (ESJI) , International Innovative Journal Impact Factor (IIJIF) , Science Library Index, Dubai, United Arab Emirates , Pubmed Database [NLM ID: 101669306] (Under Process) , IP Indexing (IP Value 2.40) , Web of Science Group (Under Process) , Directory of Research Journals Indexing , Scholar Article Journal Index (SAJI) , International Scientific Indexing ( ISI ) , 

 ISSN 2394-3211

Impact Factor: 6.222

 ICV - 79.57



Bhatt Priyanka*, Kumar Arun and Kothiyal Preeti


Introduction: Diabetic nephropathy is a chronic micro vascular complication of diabetes mellitus which affects the kidneys and is one of the common reasons for End Stage Renal Disease leading to mortality and morbidity. Hyperglycemia induces oxidative stress and leads to activation of multiple biochemical pathways which are a major source of kidney damage. Thus, prevention and treatment of diabetic nephropathy can reduce the incidence of end stage renal disease, death and ultimately the economic burden. Currently treatments available for diabetic nephropathy are limited so more investigations are needed to improve the condition of the patients. The present study involves investigation of the effect of MAO-B inhibitor in diabetic nephropathic animals. Methods: Male wistar rats, weighing 150-250 g were randomized into nine groups (n=7). Diabetes was induced by administering Streptozotocin (65mg/kg, i.p.) 15 min after nicotinamide (110 mg/kg, i.p.) injection. Starting from 5th week, post nicotinamide (NAD)-Streptozotocin (STZ) injection, Rasagiline (RG) and Glimepiride (GP) were administered for 4 weeks. Serum glucose, body weight, serum creatinine, and serum urea were measured weekly. Malondialdehyde measurement and histopathology of kidney was carried out at the end of the study. Results: After 28 days of treatment with RG (0.5, 1.0 mg/kg, i.p), significant reduction in serum urea, serum creatinine and lipid peroxidation was observed. No significant effect was observed on serum glucose and body weight as compared to diabetic control. RG (0.5, 1.0 mg/kg, i.p) in combination with GP (10mg/kg, i.p) showed significant reduction in serum glucose, serum urea, serum creatinine and lipid peroxidation. Improvement in body weight was also observed in STZ induced diabetic rats as compared to diabetic control. Conclusion: The present study concludes that Combination of RG and GP not only attenuates the diabetes but also reverses the nephropathic signs through its nephroprotective actions and thus RG may serve as a new therapeutic alternative for management in nephropathy associated with type-2 diabetes.

Keywords: Diabetic nephropathy, Rasagiline, oxidative stress, renal function test.

[Full Text Article]



  • New Issue Published

    Its Our pleasure to inform you that, EJPMR 1 November 2021 Issue has been Published, Kindly check it on


    NOVEMBER Issue has been successfully launched on 1 November 2021.

  • EJPMR New Impact Factor

    Its our Pleasure to Inform you that EJPMR Impact Factor has been increased from  5.804 to 6.222, due to high quality Publication at International Level

  • Index Copernicus Value

    EJPMR Received Index Copernicus Value 79.57, due to High Quality Publication in EJPMR at International Level

  • Journal web site support Internet Explorer, Google Chrome, Mozilla Firefox, Opera, Saffari for easy download of article without any trouble.


  • Article Invited for Publication

    Article are invited for publication in EJPMR Coming Issue

Google Scholar Indian Science Publications InfoBase Index (In Process) SOCOLAR, China Research Bible, Fuchu, Tokyo. JAPAN International Society for Research activity (ISRA) Scientific Indexing Services (SIS) Polish Scholarly Bibliography Global Impact Factor (GIF) (Under Process) Universal Impact Factor International Scientific Indexing (ISI), UAE Index Copernicus CAS (A Division of American Chemical Society) USA (Under Process) Directory of Open Access Journal (DOAJ, Sweden, in process) UDLedge Science Citation Index CiteFactor Directory Of Research Journal Indexing (DRJI) Indian citation Index (ICI) Journal Index (JI, Under Process) Directory of abstract indexing for Journals (DAIJ) Open Access Journals (Under Process) Impact Factor Services For International Journals (IFSIJ) Cosmos Impact Factor Jour Informatics (Under Process) Eurasian Scientific Journal Index (ESJI) International Innovative Journal Impact Factor (IIJIF) Science Library Index, Dubai, United Arab Emirates Pubmed Database [NLM ID: 101669306] (Under Process) IP Indexing (IP Value 2.40) Web of Science Group (Under Process) Directory of Research Journals Indexing Scholar Article Journal Index (SAJI) International Scientific Indexing ( ISI )